photo

Global Smart Inhaler Market Current Analysis and Forecast (2019-2026) Emphasis on Product (Inhalers (Metered Dose Inhalers, Dry Powder Inhalers), Nebulizers), By Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel), End-user (Hospitals & Clinics, Respiratory Care Centers, Others) and Region/Country

Report ID : BRR23-752
Category : Pharmaceutical and Healthcare
Published Date : 23 January 2020
Pages : 224

Smart Inhaler Market

Global Smart Inhaler Market was valued at US$ 1,655.2 million in 2019 and is anticipated to reach US$ 4,563.1 million by 2026 displaying an elevated CAGR of 15.7% over the forecast period (2020-2026).

Smart inhalers are the devices that are used for delivering a variety of medication through inhalation. The drugs used in the inhalers include anti-cholinergic, glucocorticoids, insulin, and beta-agonists for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases. The global smart inhalers market trends have gained momentum in the healthcare industry due to cost-effectiveness and increased adherence to the treatment by patients owing to the presence of sensors attached to the inhalers, which stores data measuring the amount of dosage, increasing the efficiency of the drug. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, the rise in air pollution, and growth in healthcare burden, owing to higher cases of asthma and COPD. Amongst the prevalence of COPD and asthma, COPD is expected to be the third leading cause of death globally by 2030. Better treatment options, ease of use, and technological advancements coupled with the increase in adherence rate of patients to smart inhalers are other major factors that drive this market. However, the lack of reimbursement for smart inhalers and limited availability of smart inhalers in developing regions are expected to restrain the global smart inhalers' market growth.

“Amongst product type, Inhalers dominated the global smart inhalers market, with 88.6% share and is projected to dominate the market by 2026.”

Based on product type, the report bifurcates the global smart inhalers market into Inhaler (Metered Dose Inhalers, Dry Powder Inhalers) and nebulizers. The market of metered-dose inhalers is expected to grow tremendously at a CAGR of 15.1% during the forecast period 2020-2026, due to the high adoption of these devices.

“Chronic Obstructive Pulmonary Disorder (COPD) indication segment is expected to dominate the use of smart inhalers in 2018, however Asthma indication would grow at highest CAGR growth”

Based on indication, the global smart inhaler market is segmented into Chronic Obstructive Pulmonary Disorder (COPD) and asthma. The COPD occupied the largest share and is expected to maintain its dominance throughout the forecast period 2020-2026 owing to COPD is expected to be the third leading cause of death globally by 2030. The segment generated revenue of US$ 835.5 million in 2018.

“Hospital Pharmacies was the most preferred distribution channel for smart inhalers; however, Online Pharmacies  are expected to witness high adoption during the analyzed period”

On the basis of distribution channel, the report segments the global smart inhaler market into Hospital Pharmacies, Retail Pharmacies and Retail Pharmacies. In 2018, Hospital Pharmacies were the most preferred channel of distribution accounting for more than 70% share.

“Amongst end-user, Hospitals & Clinics is anticipated to dominate the Global Smart Inhaler market by 2026.”

Based on end-users the global smart inhaler market is segmented into Hospitals & Clinics, Respiratory Care Centre and others. In 2018, Hospitals & Clinics were the largest end-users of smart inhalers and is expected to remain dominance during the analysed period. However, Respiratory Care Centre are expected to witness CAGR growth of 17.7% during 2020-2026 period.

“North America represents as the largest market for smart inhaler globally, followed by Europe and Asia-Pacific”

For a deep-dive analysis of the industry, the study also includes Global regional-level analysis includes major markets of the Smart Inhaler market in North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Spain, Italy and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific) and Rest of the world. In 2018, North America generated revenue of US$ 651.0 million and is expected to reach US$ 1,904.8 million by 2026. The dominance is owing to the high prevalence of respiratory disorders and rising old age population along with high awareness among the people.

Competitive Landscape-Top 10 Market Players

Boehringer Ingelheim, Cohero Health, Inc., Omron Corporation, Novartis, AstraZeneca, Teva Pharmaceuticals Industries Ltd., Vectura Group, GlaxoSmithKline, Adherium Limited, 3M are some of the prominent players operating in the Global Smart Inhaler market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Global Smart Inhaler Market Segmentation

Market Insights, by Product Type

  • Inhalers
    • Metered Dose Inhalers
    • Dry Powder Inhalers
  • Nebulizers

Market Insights, by Indication

  • COPD
  • Asthma

Market Insights, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Insights, by End-User

  • Hospitals & Clinics
  • Respiratory Care Centre
  • Others

Market Insights, by Region

  • North America Smart Inhaler market
    • United States
    • Canada
    • Rest of North America
  • Europe Smart Inhaler market
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific Smart Inhaler market
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World Smart Inhaler market

Top Company Profiles

  • Boehringer Ingelheim group
  • Cohero Health, Inc.
  • Omron Corporation
  • Novartis AG
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Limited
  • Vectura Group plc
  • GlaxoSmithKline
  • Adherium Limited
  • 3M Drug Delivery Systems

Reasons to buy:

  • Current and future market size from 2018 to 2026 in terms of value (US$)
  • Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry
  • Country-level details of the overall adoption of Smart Inhaler market and several case studies of the patients who have adopted smart inhalers
  • A quick review of overall industry performance at a glance
  • In-depth analysis of key industry players
  • A detailed analysis of drivers, restraints, key trends and opportunities prevailing in the industry
  • Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups
  • The study comprehensively covers the market across different segments and sub-segments of the technology
  • Region/country Covered: North America (US, Canada and Rest of North America), Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia and Rest of Asia-Pacific), and Rest of World

Customization Options:

BRR understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Smart Inhaler market can be customized to the country level or any other market segment.

1 MARKET INTRODUCTION
    1.1 Market Definition
    1.2 Objective of the Study
    1.3 Limitation    
    1.4 Stakeholders  
    1.5 Currency used in the Report
    1.6 Scope of the Global Smart Inhaler Market Study
  2 RESEARCH METHODOLOGY
    2.1 Research Methodology adopted for Global Smart Inhaler Market study
      2.1.1 Main objective of the Global Smart Inhaler Market Study
  3 REGULATORY FRAMEWORK
    3.1 General Overview
      3.1.1 US Regulations for Wearable Medical Devices
        3.1.1.1 Legal Framework for Medical Device Regulation
        3.1.1.2 FDA Flexibility on Low-Risk Mobile Applications
        3.1.1.3 Legal Framework for Health Data Privacy
      3.1.2 Japan Regulations for Wearable Medical Devices
        3.1.2.1 List of software Under Regulation
        3.1.2.2 Legal Framework for Health Data Privacy
      3.1.3 European Regulations for Wearable Medical Devices
        3.1.3.1 EU Strict Rules on Medical Device Software
        3.1.3.2 Legal Framework for Health Data Privacy
  4 INDUSTRY PERFORMANCE
  5 EXECUTIVE SUMMARY  
  6 MARKET OVERVIEW  
    6.1 Introduction  
    6.2 Market Dynamics  
      6.2.1 Market Drivers
        6.2.1.1 Accelerating Geriatric Population
        6.2.1.2 Increasing Prevalence of Respiratory Disorders
        6.2.1.3 Rising Air Pollution
        6.2.1.3.1 Facts About Air Pollution:
        6.2.1.4 Rising Healthcare Expenditure and Health-Conscious Personals
        6.2.1.5 Growing Penetration of Smart Phones
      6.2.2 Market Restraints
        6.2.2.1 Overall High Cost of Inhalers
        6.2.2.2 Misusing Data and Data Privacy
        6.2.2.3 Lack of Awareness
      6.2.3 Market Trends
        6.2.3.1 Increasing demand for connected devices
        6.2.3.2 Significant Growth in IoMT Market
  7 EMERGENCE OF SMART INHALER MARKET
    7.1 General Overview
    7.2 Connected Device as a Solution
      7.2.1 Potential Benefits of Smart Inhaler
        7.2.1.1 Patients:
        7.2.1.2 Healthcare provider:
        7.2.1.3 Pharmaceutical company:
    7.3 Partnerships Between Several Pharma and Technology/ Device Companies
  8 PATIENT CONCERNS REGARDING SMART INHALERS AND CASE STUDIES
    8.1 The Survey    
    8.2 Case Studies  
      8.2.1 Lyndsey Affected with Poor Asthma Symptoms
      8.2.2 Jaswinder Seeking Solution for Her Daughter’s Asthma
      8.2.3 Adrian Using Connected Peak Flow for Monitoring Asthma
      8.2.4 Matthew Worrying About the Worsening of His Asthma
  9 KEY MARKET INDICATORS
    9.1 Demand Side Analysis
    9.2 Supply Side Analysis
      9.2.1 Product Launch
      9.2.2 Partnerships
      9.2.3 Business Expansion & Investments
      9.2.4 Merger and Acquisitions
    9.3 Value Chain Analysis of Smart Inhaler Market
  10 MARKET INSIGHTS BY PRODUCT
    10.1 General Overview
      10.1.1 Inhalers  
        10.1.1.1 Dry Powder Inhaler (DPI)
        10.1.1.2 Metered Dose Inhaler (MDI)
      10.1.2 Nebulizers  
  11 MARKET INSIGHTS BY INDICATION
    11.1 General Overview
      11.1.1 Chronic Obstructive Pulmonary Disease (COPD)
      11.1.2 Asthma  
  12 MARKET INSIGHTS BY DISTRIBUTION CHANNEL
    12.1 General Overview
      12.1.1 Hospital Pharmacies
      12.1.2 Retail Pharmacies
      12.1.3 Online Channel
  13 MARKET INSIGHTS, BY END-USER
    13.1 General Overview
      13.1.1 Hospitals & Clinics
      13.1.2 Respiratory Care Centre
      13.1.3 Others  
  14 MARKET INSIGHTS BY REGION/COUNTRY
    14.1 General Overview
    14.2 North America Smart Inhaler Market
      14.2.1 North America Smart Inhalers Market, by Product
      14.2.2 North America Smart Inhalers Market, by Indication
      14.2.3 North America Smart Inhalers Market, by Distribution Channel
      14.2.4 North America Smart Inhalers Market, by End-Users
      14.2.5 North America Smart Inhalers Market, by Country
        14.2.5.1 United States Smart Inhaler Market
          14.2.5.1.1 Key Findings on Healthcare Spending in the US, 2017
          14.2.5.1.2 US Health Spending by Type of Service or Product, 2017
          14.2.5.1.3 Health Spending by Major Sources of Funds
          14.2.5.1.4 US Smart Inhalers Market, by Product
          14.2.5.1.5 US Smart Inhalers Market, by Indication
          14.2.5.1.6 US Smart Inhalers Market, by Distribution Channel
          14.2.5.1.7 US Smart Inhalers Market, by End-Users
        14.2.5.2 Canada Smart Inhaler Market
          14.2.5.2.1 Key Facts on Total Hospital Cost, by Health Conditions Canada, 2016
          14.2.5.2.2 Key Findings on Canada Healthcare Spending, 2018
          14.2.5.2.3 Key Findings on Hospital sector Spending in Canada, 2018
          14.2.5.2.4 Canada Smart Inhalers Market, by Product
          14.2.5.2.5 Canada Smart Inhalers Market, by Indication
          14.2.5.2.6 Canada Smart Inhalers Market, by Distribution Channel
          14.2.5.2.7 Canada Smart Inhalers Market, by End-Users
        14.2.5.3 Rest of the NA Smart Inhaler Market
          14.2.5.3.1 Key Findings on Healthcare Spending in Mexico, 2016
          14.2.5.3.2 Rest of NA Smart Inhalers Market, by Product
          14.2.5.3.3 Rest of NA Smart Inhalers Market, by Indication
          14.2.5.3.4 Rest of NA Smart Inhalers Market, by Distribution Channel
          14.2.5.3.5 Rest of NA Smart Inhalers Market, by End-Users
    14.3 Europe Smart Inhaler Market
      14.3.1 Europe Smart Inhalers Market, by Product
      14.3.2 Europe Smart Inhalers Market, by Indication
      14.3.3 Europe Smart Inhalers Market, by Distribution Channel
      14.3.4 Europe Smart Inhalers Market, by End-Users
      14.3.5 Europe Smart Inhalers Market, by Country
        14.3.5.1 Germany Smart Inhaler Market
          14.3.5.1.1 Facts on COPD and Asthma in Germany
          14.3.5.1.2 Germany Smart Inhalers Market, by Product
          14.3.5.1.3 Germany Smart Inhalers Market, by Indication
          14.3.5.1.4 Germany Smart Inhalers Market, by Distribution Channel
          14.3.5.1.5 Germany Smart Inhalers Market, by End-Users
        14.3.5.2 United Kingdom Smart Inhaler Market
          14.3.5.2.1 United Kingdom Smart Inhalers Market, by Product
          14.3.5.2.2 United Kingdom Smart Inhalers Market, by Indication
          14.3.5.2.3 United Kingdom Smart Inhalers Market, by Distribution Channel
          14.3.5.2.4 United Kingdom Smart Inhalers Market, by End-Users
        14.3.5.3 Spain Smart Inhaler Market
          14.3.5.3.1 Spain Smart Inhalers Market, by Product
          14.3.5.3.2 Spain Smart Inhalers Market, by Indication
          14.3.5.3.3 Spain Smart Inhalers Market, by Distribution Channel
          14.3.5.3.4 Spain Smart Inhalers Market, by End-Users
        14.3.5.4 France Smart Inhaler Market
          14.3.5.4.1 France Smart Inhalers Market, by Product
          14.3.5.4.2 France Smart Inhalers Market, by Indication
          14.3.5.4.3 France Smart Inhalers Market, by Distribution Channel
          14.3.5.4.4 France Smart Inhalers Market, by End-Users
        14.3.5.5 Italy Smart Inhaler Market
          14.3.5.5.1 Italy Smart Inhalers Market, by Product
          14.3.5.5.2 Italy Smart Inhalers Market, by Indication
          14.3.5.5.3 Italy Smart Inhalers Market, by Distribution Channel
          14.3.5.5.4 Italy Smart Inhalers Market, by End-Users
        14.3.5.6 Rest of Europe Smart Inhaler Market
          14.3.5.6.1 Rest of Europe Smart Inhalers Market, by Product
          14.3.5.6.2 Rest of Europe Smart Inhalers Market, by Indication
          14.3.5.6.3 Rest of Europe Smart Inhalers Market, by Distribution Channel
          14.3.5.6.4 Rest of Europe Smart Inhalers Market, by End-Users
    14.4 Asia-Pacific Smart Inhaler Market
      14.4.1 Asia-Pacific Smart Inhalers Market, by Product
      14.4.2 Asia-Pacific Smart Inhalers Market, by Indication
      14.4.3 Asia-Pacific Smart Inhalers Market, by Distribution Channel
      14.4.4 Asia-Pacific Smart Inhalers Market, by End-Users
      14.4.5 Asia-Pacific Smart Inhalers Market, by Country
        14.4.5.1 China Smart Inhaler Market
          14.4.5.1.1 China Smart Inhalers Market, by Product
          14.4.5.1.2 China Smart Inhalers Market, by Indication
          14.4.5.1.3 China Smart Inhalers Market, by Distribution Channel
          14.4.5.1.4 China Smart Inhalers Market, by End-Users
        14.4.5.2 India Smart Inhaler Market
          14.4.5.2.1 India Smart Inhalers Market, by Product
          14.4.5.2.2 India Smart Inhalers Market, by Indication
          14.4.5.2.3 India Smart Inhalers Market, by Distribution Channel
          14.4.5.2.4 India Smart Inhalers Market, by End-Users
        14.4.5.3 Japan Smart Inhaler Market
          14.4.5.3.1 Changing Demographic Structure of Japan
          14.4.5.3.2 Japan Smart Inhalers Market, by Product
          14.4.5.3.3 Japan Smart Inhalers Market, by Indication
          14.4.5.3.4 Japan Smart Inhalers Market, by Distribution Channel
          14.4.5.3.5 Japan Smart Inhalers Market, by End-Users
        14.4.5.4 Australia Smart Inhaler Market (2018-2025)
          14.4.5.4.1 Australia Smart Inhalers Market, by Product
          14.4.5.4.2 Australia Smart Inhalers Market, by Indication
          14.4.5.4.3 Australia Smart Inhalers Market, by Distribution Channel
          14.4.5.4.4 Australia Smart Inhalers Market, by End-Users
        14.4.5.5 South Korea Smart Inhaler Market
          14.4.5.5.1 South Korea Smart Inhalers Market, by Product
          14.4.5.5.2 South Korea Smart Inhalers Market, by Indication
          14.4.5.5.3 South Korea Smart Inhalers Market, by Distribution Channel
          14.4.5.5.4 South Korea Smart Inhalers Market, by End-Users
        14.4.5.6 Rest of Asia-Pacific Smart Inhaler Market (2018-2025)
          14.4.5.6.1 Rest of APAC Smart Inhalers Market, by Product
          14.4.5.6.2 Rest of APAC Smart Inhalers Market, by Indication
          14.4.5.6.3 Rest of APAC Smart Inhalers Market, by Distribution Channel
          14.4.5.6.4 Rest of APAC Smart Inhalers Market, by End-Users
    14.5 Rest of World Smart Inhaler Market (2018-2025)
      14.5.1 Rest of World Smart Inhalers Market, by Product
      14.5.2 Rest of World Smart Inhalers Market, by Indication
      14.5.3 Rest of World Smart Inhalers Market, by Distribution Channel
      14.5.4 Rest of World Smart Inhalers Market, by End-Users
  15 COMPETITIVE SCENARIO
    15.1 Porter’s Five forces analysis
      15.1.1 Bargaining Power of Buyers
      15.1.2 Bargaining power of Supplier
      15.1.3 Threat of new entrants
      15.1.4 Availability of Substitute
      15.1.5 Industry Rivalry
    15.3 Market Share Analysis, by Company 2019
  16 TOP COMPANY PROFILES
    16.1 Boehringer Ingelheim
      16.1.1 Key Facts  
      16.1.2 Business Description
      16.1.3 Key Product/Services Offerings
      16.1.4 Growth Strategy
      16.1.5 SWOT Analysis
      16.1.6 Key Financials (2014-2018)
      16.1.7 Revenue Split
      16.1.8 Recent Developments
        16.1.8.1 Product Launches
        16.1.8.2 Business Expansion and Investments
    16.2 Cohero Health, Inc.
      16.2.1 Key Facts  
      16.2.2 Business Description
      16.2.3 Key Product/Services Offerings
      16.2.4 Growth Strategy
      16.2.5 SWOT Analysis
      16.2.6 Recent Developments
        16.2.6.1 Product Launches
        16.2.6.2 Investment
    16.3 Omron Corporation
      16.3.1 Key Facts  
      16.3.2 Business Description
      16.3.3 Key Product/Services Offerings
      16.3.4 Growth Strategy
      16.3.5 SWOT Analysis
      16.3.6 Key Financials (2014-2018)
      16.3.7 Revenue Split
    16.4 Novartis    
      16.4.1 Key Facts  
      16.4.2 Business Description
      16.4.3 Key Product/Services Offerings
      16.4.4 Growth Strategy
      16.4.5 SWOT Analysis
      16.4.6 Key Financials (2014-2018)
      16.4.7 Revenue Split
    16.5 AstraZeneca  
      16.5.1 Key Facts  
      16.5.2 Business Description
      16.5.3 Key Product/Services Offerings
      16.5.4 Growth Strategy
      16.5.5 SWOT Analysis
      16.5.6 Key Financials
      16.5.7 Revenue Split
      16.5.8 Recent Developments
        16.5.8.1 Product Launches
        16.5.8.2 Business Expansion
    16.6 Teva Pharmaceuticals Industries Ltd.
      16.6.1 Key Facts  
      16.6.2 Business Description
      16.6.3 Key Product/Services Offerings
      16.6.4 Growth Strategy
      16.6.5 SWOT Analysis
      16.6.6 Key Financials (2014-2018)
      16.6.7 Revenue Split
      16.6.8 Recent Developments
        16.6.8.1 Product Launch
        16.6.8.2 Business Expansion
    16.7 Vectura Group  
      16.7.1 Key Facts  
      16.7.2 Business Description
      16.7.3 Key Product/Services Offerings
      16.7.4 Growth Strategy
      16.7.5 SWOT Analysis
      16.7.6 Key Financials
      16.7.7 Revenue Split
      16.7.8 Recent Developments
        16.7.8.1 Product Launches
        16.7.8.2 Partnership
    16.8 GlaxoSmithKline  
      16.8.1 Key Facts  
      16.8.2 Business Description
      16.8.3 Key Product/Services Offerings
      16.8.4 Growth Strategy
      16.8.5 SWOT Analysis
      16.8.6 Key Financials
      16.8.7 Revenue Split
      16.8.8 Recent Developments
        16.8.8.1 Product Launches
        16.8.8.2 Merger and Acquisitions
    16.9 Adherium Limited
      16.9.1 Key Facts  
      16.9.2 Business Description
      16.9.3 Key Product/Services Offerings
      16.9.4 Growth Strategy
      16.9.5 SWOT Analysis
      16.9.6 Key Financials (2014-2018)
        16.9.6.1 Revenue Split
      16.9.7 Recent Developments
        16.9.7.1 Product Launches
        16.9.7.2 Partnership
    16.1 3M      
      16.10.1 Key Facts  
      16.10.2 Business Description
      16.10.3 Key Product/Services Offerings
      16.10.4 SWOT Analysis
      16.10.5 Key Financials
      16.10.6 Revenue Split
      16.10.7 Recent Developments
        16.10.7.1 Product Launches
Global Smart Inhaler Market 2019-2026

Choose Package

Report Enquiry

Captcha Code is Incorrect.

Need More Information

USA : +1 7162260907

UK : +44 7441952057

sales@businessresearchreports.com

Latest Posts

Global In Store Analytics Market Size By Application, By Deployment Mode, By Geographic Scope And Forecast 2026

According to Business Research Reports, Global In-Store Analytics Market was valued at USD 941 Million in 2018 and is projected to reach USD 4,252.1 Million by 2026, growing at a CAGR of 20.64% from 2019 to 2026.

February 2020 | Price: $3950

View Details

Global Intelligent Pdu Market Size By Type, By Application, By End-Use Industry, By Geographic Scope And Forecast 2026

According to Business Research Reports, Global Intelligent PDU Market was valued at USD 1.32 Billion in 2018 and is projected to reach USD 2.48 Billion by 2026, growing at a CAGR of 8.12% from 2019 to 2026.

February 2020 | Price: $3950

View Details

Middle East & Africa Cybersecurity Market Size By Deployment Model, By Service Type, By Application And Forecast 2026

According to Business Research Reports, Middle East & Africa Cybersecurity Market was valued at USD 5.92 Billion in 2018 and is projected to reach USD 17.30 Billion by 2026, growing at a CAGR of 14.35% from 2019 to 2026.

February 2020 | Price: $3950

View Details